AbbVie Inc. (VIE:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 317.75 billion. The enterprise value is 372.61 billion.

Market Cap	317.75B
Enterprise Value	372.61B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Jul 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 100.23 and the forward PE ratio is 16.00.

PE Ratio	100.23
Forward PE	16.00
PS Ratio	6.40
PB Ratio	-2,704.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.34, with an EV/FCF ratio of 23.99.

EV / Earnings	117.54
EV / Sales	7.47
EV / EBITDA	15.34
EV / EBIT	22.01
EV / FCF	23.99

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	903,023
Profits Per Employee	57,639
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-630.96M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.46%
50-Day Moving Average	167.40
200-Day Moving Average	171.76
Relative Strength Index (RSI)	59.22
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, AbbVie had revenue of EUR 49.67 billion and earned 3.17 billion in profits. Earnings per share was 1.79.

Revenue	49.67B
Gross Profit	35.38B
Operating Income	16.86B
Pretax Income	2.58B
Net Income	3.17B
EBITDA	23.91B
EBIT	16.86B
Earnings Per Share (EPS)	1.79

Balance Sheet

The company has 5.51 billion in cash and 60.10 billion in debt, giving a net cash position of -54.60 billion.

Cash & Cash Equivalents	5.51B
Total Debt	60.10B
Net Cash	-54.60B
Net Cash Per Share	n/a
Equity (Book Value)	-117.51M
Book Value Per Share	-0.09
Working Capital	-8.95B

Cash Flow

In the last 12 months, operating cash flow was 16.42 billion and capital expenditures -888.97 million, giving a free cash flow of 15.53 billion.

Operating Cash Flow	16.42B
Capital Expenditures	-888.97M
Free Cash Flow	15.53B
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

This stock pays an annual dividend of 5.86, which amounts to a dividend yield of 3.30%.

Dividend Per Share	5.86
Dividend Yield	3.30%
Dividend Growth (YoY)	3.22%
Years of Dividend Growth	8
Payout Ratio	301.30%
Buyback Yield	-0.03%
Shareholder Yield	3.27%
Earnings Yield	1.00%
FCF Yield	4.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6